Literature DB >> 583423

Luekocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy.

J R Wall, B A Walters, C Grant.   

Abstract

Leukocyte adherence inhibition (LAI) may be a test for cell-mediated immunity or cytophilic antibodies. LAI tests were carried out on patients with Graves' ophthalmopathy, using normal human lacrimal gland, orbital fat, and eye muscle extracts as antigens. The results were expressed as % LAI. The percentage leukocyte adherence inhibition in tests from patients and normal subjects were not significantly different for any preparation (Mann-Whitney tests). Taking the upper limit of normal as the mean % LAI + 2SD for normal subjects, tests were positive, to eye muscle extract, in only one patient whilst borderline inhibition, in response to eye muscle and fat extracts respectively, was demonstrated in two patients. All three had active disease. LAI tests may be positive only during the acute stage of Graves' ophthalmopathy. The significance of these findings in respect to the pathogenesis of Graves' ophthalmopathy is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583423     DOI: 10.1007/BF03349336

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  The role of autoimmunity in hypoendocrine and hyperendocrine function: with special emphasis on autoimmune thyroid disease.

Authors:  R Volpé
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

2.  Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane.

Authors:  J Konishi; M M Herman; J P Kriss
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

3.  Detection of antibodies which can cooperate with lymphocytes.

Authors:  O Fakhri; J R Hobbs
Journal:  Lancet       Date:  1972-08-26       Impact factor: 79.321

4.  Cell-mediated immunity and serum blocking factors in patients with chronic dermatophytic infections.

Authors:  B A Walters; J E Chick; W J Halliday
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

5.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle.

Authors:  B R Mullin; R E Levinson; A Friedman; D E Henson; R J Winand; L D Kohn
Journal:  Endocrinology       Date:  1977-02       Impact factor: 4.736

7.  Relationship of thyrotropin to exophthalmos-producing substance. Formation of an exophthalmos-producing substance by pepsin digestion of pituitary glycoproteins containing both thyrotropic and exophthalmogenic activity.

Authors:  L D Kohn; R J Winand
Journal:  J Biol Chem       Date:  1971-11       Impact factor: 5.157

8.  Tube leukocyte adherence inhibition assay for the detection of anti-tumor immunity. I. Monocyte is the reactive cell.

Authors:  N Grosser; J H Marti; J W Proctor; D M Thomson
Journal:  Int J Cancer       Date:  1976-07-15       Impact factor: 7.396

9.  A modified leukocyte adherence inhibition test in the laboratory investigation of gastrointestinal cancer.

Authors:  J C Rutherford; B A Walters; G Cavaye; W J Halliday
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

10.  Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test.

Authors:  R E Munro; L Lamki; V V Row; R Volpé
Journal:  J Clin Endocrinol Metab       Date:  1973-08       Impact factor: 5.958

View more
  4 in total

Review 1.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  T and B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy.

Authors:  A P Weetman; P Fells; B Shine
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

3.  Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.

Authors:  M Mengistu; E Laryea; A Miller; J R Wall
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

Review 4.  Graves' ophthalmopathy.

Authors:  J R Wall; J Henderson; C R Strakosch; D M Joyner
Journal:  Can Med Assoc J       Date:  1981-04-01       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.